Freedom of information requests in biotech

Introduction

Freedom of Information (FOI) requests refer to legal applications through which individuals, researchers, journalists and organisations seek access to information held by government authorities and public institutions. In biotechnology, such requests may concern genetic engineering approvals, clinical research, biosafety assessments, genetically modified crops, pharmaceutical research, environmental impact reports and government-funded scientific projects.

Access to biotechnology-related information promotes transparency, scientific accountability and public participation in regulatory decision-making. However, disclosure must be balanced against commercial confidentiality, intellectual property rights, personal privacy and national security.

In India, the principal legislation governing access to government-held information is the Right to Information Act, 2005.

Legal framework in India

1. Right to Information Act, 2005

The RTI Act provides citizens with the right to obtain information held by public authorities. Under Section 3, all citizens have the right to information, subject to the provisions of the Act.

Section 4 requires public authorities to maintain records and proactively disclose specified categories of information.

Section 6 establishes the procedure for submitting information requests, while Section 7 provides the framework for responding to applications.

In biotechnology, citizens may seek information concerning:

Government approvals for genetically modified organisms.

Biosafety assessment reports.

Publicly funded biotechnology research.

Environmental clearances for biotechnology facilities.

Regulatory inspection reports.

Government policies concerning genetic engineering.

Research expenditure and public grants.

2. Environment (Protection) Act, 1986

This Act provides the legal framework for environmental protection and regulation of hazardous activities. Information concerning environmental approvals and regulatory compliance may be accessible through applicable disclosure laws, subject to lawful exemptions.

3. Biological Diversity Act, 2002

The Act regulates access to biological resources and associated traditional knowledge in specified circumstances. Information concerning approvals and benefit-sharing arrangements may be relevant to public accountability, subject to confidentiality and statutory restrictions.

4. Digital Personal Data Protection Act, 2023

The legislation establishes a framework for processing digital personal data. Its applicable provisions and exemptions must be considered when requests involve identifiable genetic, medical or research-participant information.

Procedure for filing biotechnology-related RTI requests

A citizen seeking biotechnology information from a public authority generally follows these steps:

1. Identify the public authority

The applicant must identify the government department or institution holding the requested records. Relevant authorities may include the Department of Biotechnology, FSSAI, Ministry of Environment, Forest and Climate Change or other regulatory bodies.

2. Submit the application

An application may be submitted to the concerned Central or State Public Information Officer, depending on the authority involved.

3. Specify the information required

The request should clearly identify the documents or records sought. For example, an applicant may request copies of publicly disclosable biosafety approval orders relating to a particular biotechnology project.

4. Payment of prescribed fees

The applicant must pay the applicable application fee, subject to statutory exemptions.

5. Response by the authority

Under Section 7, information is generally required to be provided within 30 days. Different statutory timelines apply in certain circumstances, including applications concerning life or liberty.

6. Appeal mechanism

If information is refused, incomplete or not provided within the prescribed period, the applicant may file a first appeal under Section 19(1). A second appeal may be filed before the Central or State Information Commission under Section 19(3).

Restrictions on disclosure of biotechnology information

Although transparency is important, all biotechnology information cannot automatically be disclosed.

Section 8 of the RTI Act provides exemptions, including:

1. Commercial confidence and trade secrets

Section 8(1)(d) protects commercial confidence, trade secrets and intellectual property information where disclosure would harm the competitive position of a third party, unless larger public interest justifies disclosure.

2. Personal information

Section 8(1)(j), as amended by the Digital Personal Data Protection Act, 2023, addresses information relating to personal information. This is particularly relevant to genetic profiles, clinical trial participants and identifiable medical records.

3. National security

Information affecting national security or strategically sensitive biotechnology research may be protected under applicable statutory exemptions.

4. Third-party information

Section 11 establishes a consultation procedure where information relating to a third party is involved and is treated as confidential, subject to the statutory framework.

Important case laws

1. State of Uttar Pradesh v. Raj Narain (1975)

The Supreme Court recognised that citizens have a right to know about public acts performed by public officials, subject to legitimate confidentiality requirements.

This judgment provides a constitutional foundation for transparency in government biotechnology decisions, including regulatory approvals and public research expenditure.

2. Central Board of Secondary Education v. Aditya Bandopadhyay (2011)

The Supreme Court explained the scope of the RTI Act and held that public authorities are required to provide information available in their records. They are not generally required to create new information or undertake research for applicants.

This principle is relevant when requesting existing biosafety reports, inspection records or biotechnology approval documents.

3. Girish Ramchandra Deshpande v. Central Information Commissioner (2013)

The Supreme Court examined the protection of personal information under the RTI Act and recognised that personal records cannot automatically be disclosed without satisfying applicable legal requirements.

The judgment is relevant to biotechnology research involving confidential genetic information and identifiable clinical trial participants.

4. Reserve Bank of India v. Jayantilal N. Mistry (2016)

The Supreme Court emphasised transparency and public accountability in the disclosure of information held by public institutions. It also examined the limits of fiduciary and confidentiality-based exemptions.

The judgment is relevant to public biotechnology regulators because information concerning regulatory supervision and public-interest decisions may require disclosure, subject to statutory exemptions.

International legal framework

International instruments also support access to scientific and environmental information.

Universal Declaration of Human Rights, 1948: Article 19 recognises freedom of expression, including the freedom to seek and receive information.

International Covenant on Civil and Political Rights, 1966: Article 19 protects the right to seek, receive and impart information.

Convention on Biological Diversity, 1992: Promotes public awareness and access to relevant biodiversity information.

Cartagena Protocol on Biosafety, 2000: Encourages public awareness and participation concerning the safe transfer, handling and use of living modified organisms.

These instruments strengthen the principle that public access to relevant scientific and environmental information supports accountable governance.

Challenges in biotechnology information disclosure

Several difficulties arise when applying freedom-of-information laws to biotechnology:

Protection of confidential genetic and medical information.

Disputes concerning commercial secrets and patented technologies.

Technical complexity of biosafety reports.

Incomplete or fragmented regulatory records.

Balancing scientific transparency with national security.

Delays in obtaining information from multiple regulatory authorities.

Public authorities should adopt proper record-management systems and disclose non-confidential information proactively.

Conclusion

Freedom of information requests play an important role in promoting transparency and accountability in biotechnology governance. India's Right to Information Act, 2005 provides citizens with a legal mechanism to obtain government-held information concerning biosafety approvals, scientific research and regulatory decisions. However, disclosure must be balanced against privacy, intellectual property and legitimate commercial confidentiality. Judicial decisions such as State of Uttar Pradesh v. Raj Narain, CBSE v. Aditya Bandopadhyay and RBI v. Jayantilal N. Mistry establish important principles concerning public access to information. Effective implementation of transparency laws can strengthen public trust, scientific accountability and responsible biotechnology regulation.